Chapter 40:The Quiet Room

Four days into the job. Leah had settled into a rhythm. Arrive at 8:45. Log into ThorneVault by 9. Work on the healthcare competitive landscape analysis until noon. Lunch in the cafeteria — always the same table, always alone, always with a book or a notebook. Afternoon: more ThorneVault research, framed as deep-dive source material for the analysis. Leave at 6. Walk home. Moleskine notes. Sleep. The cover was holding. Priya had reviewed Leah's preliminary framework on Wednesday and approved the structure. David Choi had stopped by her cubicle on Thursday to ask if she needed any additional resources — she said no, and he nodded with what might have been approval. Her cubicle neighbors had learned her name but not her story. Catherine Marsh was polite, competent, and slightly reserved — exactly the profile of a junior analyst who was focused on her work. No one on the 34th floor had any reason to look deeper. Today, Leah was pursuing a thread that had been nagging her since the first day: the gap between ThorneVault's digital records and the physical archive. The healthcare database was comprehensive for the period 2015-2023, but anything before 2015 was sparse — a few scattered documents, no systematic files, no digitized board minutes or financial records. The pattern suggested a deliberate cutoff. Sometime around 2015, Thorne Group had begun digitizing its corporate records and uploading them to ThorneVault. Everything before that date remained in physical form — in filing cabinets, storage boxes, or the archive that had been moved from 245 East 54th. Leah needed to know what was in those pre-2015 files. The Voss connection — the baby swap, the murders, the original conspiracy — was more than twenty-four years old. If any documentary evidence existed, it would be in the physical archive, not in ThorneVault. But she couldn't access the physical archive without level-three clearance, and she couldn't get level-three clearance without waiting ninety days. Unless she could find another way in. --- 11:30 AM. Leah opened ThorneVault's document retrieval system — a module she hadn't explored yet. The interface was simple: a form with fields for document type, date range, department, and requestor justification. The system allowed any employee to request a document retrieval from the physical archive, which would be processed by the records management team on the 36th floor. The retrieval request form had a note at the bottom: "Standard requests are processed within 5-7 business days. Expedited requests require director approval. All retrievals are logged and audited." Logged and audited. Every document she requested would create a record — who requested it, when, and why. If Leah requested documents related to the Voss family or pre-2015 corporate activity, the request would be visible to anyone with access to the retrieval logs. She couldn't request what she actually needed. But she could request something adjacent — something that would appear legitimate while potentially yielding useful information. She drafted a retrieval request: *Document Type: Board minutes and acquisition due diligence reports* *Date Range: 2012-2015* *Department: Corporate Strategy / Costa Holdings* *Justification: Healthcare competitive landscape analysis requires historical context for Costa Holdings' acquisition strategy prior to 2015. Understanding the company's pre-existing portfolio and strategic priorities will inform the forward-looking analysis requested by David Choi.* *Requestor: Catherine Marsh, Junior Analyst, Market Analysis* The request was legitimate on its face. A junior analyst building a competitive landscape analysis would reasonably need historical context. The date range (2012-2015) was broad enough to include pre-2015 corporate activity without being specific enough to raise suspicion. The justification referenced David Choi's assignment, which gave it institutional weight. Leah submitted the request and waited for the confirmation email. It arrived within seconds: *Your document retrieval request (REQ-2024-0347) has been received. Estimated processing time: 5-7 business days. You will be notified when the documents are available for review in the Research Room on the 36th floor.* The Research Room on the 36th floor. Not the records room itself — a separate, controlled space where retrieved documents could be reviewed under supervision. That meant Leah would be granted temporary access to the 36th floor for the purpose of reviewing the requested documents. It wasn't level-three clearance. It was a visitor pass. But it would get her onto the floor. It would let her see the layout, observe the security protocols, and — most importantly — encounter Geraldine Hoffman. The records manager. Twenty-eight years at the company. The woman who knew where every document was stored, including the ones that had been moved from 245 East 54th. Leah closed the confirmation email and returned to the healthcare analysis. But she was smiling — a small, controlled smile that Catherine Marsh would never allow and Isabella Thorne would recognize. The door to the 36th floor was opening. --- 2:00 PM. Priya's weekly team meeting. The Market Analysis unit gathered in Conference Room A — eight analysts, two senior associates, and Priya. Leah sat in the back, notebook open, pen ready. The meeting was routine: project updates, upcoming deadlines, resource allocation. Leah's healthcare analysis was mentioned briefly — Priya noted that it was "on track" and asked Leah to prepare a preliminary findings summary for David by the end of next week. But the interesting part came at the end of the meeting, when Priya mentioned a development that hadn't been on the agenda. "One more item," she said. "The executive floor has requested a briefing on the Costa Holdings healthcare portfolio. David will present, and he's asked for supporting analysis from this unit. I'll need two volunteers to help prepare the briefing materials." Hands went up around the table. Leah raised hers — not too eagerly, not too slowly. Just the right level of professional interest. Priya scanned the room and pointed. "Marcus, you take the medical device segment. Catherine, you take the clinical diagnostics and pharmaceutical segment. I'll send you the briefing format this afternoon." Marcus. Leah turned to look at the man who had raised his hand — early thirties, sandy hair, earnest expression. Not the Marcus from Chesapeake. Different person entirely. But the name was another coincidence, and Leah was running out of tolerance for coincidences. The briefing for the executive floor. That meant a presentation to someone on 40 — possibly David, possibly someone above him. If Martha or Richard were involved, Leah might find herself in the same room as the people who had tried to kill her. But that was the point of the infiltration. Proximity. Access. The chance to observe, to gather intelligence, to be seen without being recognized. She would prepare the briefing materials. She would attend the briefing if asked. And she would be Catherine Marsh — professional, competent, unremarkable. Isabella Thorne would be watching from behind Catherine's eyes. --- 4:30 PM. ThorneVault. Leah was deep in the clinical diagnostics data when she found the anomaly. She had been reviewing financial models for the healthcare portfolio, cross-referencing revenue projections with actual performance data. The exercise was part of the briefing preparation — David wanted "supporting analysis" that showed Costa Holdings' healthcare investments were performing well. Most of the data was clean. Revenue projections were within standard variance ranges. Cost structures were reasonable. The portfolio was performing roughly in line with expectations. But one line item caught her eye. Under "Costa Holdings — Pharmaceutical R&D," there was a payment labeled "Voss Medical Research Foundation — Research Grant." The amount was $45,000. The date was March 2020. Voss. The name hit Leah like a physical impact. She had seen this before — in the Linden Holdings file at Chesapeake, over a year ago. A $45,000 payment to the Voss Medical Research Foundation, incorporated by Pemberton & Croft, with property transferred to Martha Thorne as trustee. Leah had researched the Voss family and found that James and Elena Voss had been killed twenty-four years ago, leaving a daughter named Isabella. Isabella. Her own name. Connected to a foundation connected to Martha Thorne. And now here it was again — the same foundation, the same name, buried in Thorne Group's financial records. A $45,000 payment from Costa Holdings' pharmaceutical R&D budget to a research foundation that was connected to the Voss family. Leah stared at the screen. Her hands were steady, but her pulse had quickened. She searched for "Voss Medical Research Foundation" in ThorneVault. The results returned four documents: 1. The original grant agreement (March 2020) — $45,000 from Costa Holdings to Voss Medical Research Foundation for "pediatric clinical trial support." 2. A follow-up report (December 2020) — the Foundation's summary of how the grant funds were used. Clinical trial enrollment, patient outcomes, research publications. Standard grant reporting. 3. A renewal agreement (March 2021) — another $45,000, same purpose. 4. A termination notice (September 2021) — the Foundation was being dissolved, and the remaining funds would be transferred to the Thorne Foundation. The termination notice was the key document. Leah opened it and read carefully. The Voss Medical Research Foundation was being dissolved effective September 30, 2021. The reason stated was "completion of the foundation's charitable mission." The remaining assets — $12,000 in a bank account and a property at 87 Rimrock Road, Southampton — were being transferred to the Thorne Foundation, with Martha Thorne named as the receiving trustee. Leah had seen this before. The property transfer. The Foundation absorption. The pattern of Martha Thorne acquiring assets that were connected to the Voss family. But this time, she had more context. The alliance with Ethan. The knowledge that her own identity might be connected to the Voss name. The growing suspicion that the conspiracy wasn't just about money or power — it was about her. She bookmarked all four documents and added to her notebook: *Voss Medical Research Foundation: $45K/yr grant from Costa Holdings R&D (2020-2021). Foundation dissolved Sep 2021. Assets transferred to Thorne Foundation (Martha, trustee). Property at 87 Rimrock Rd, Southampton — likely in Hamptons estate cluster.* *This is the third time the Voss name has appeared in the financial records: (1) Linden Holdings payment via Chesapeake, (2) Foundation incorporation by Pemberton & Croft, (3) Costa Holdings R&D grant. The Voss connection is not peripheral — it is embedded in the conspiracy's financial architecture.* *Why is Martha Thorne collecting assets connected to the Voss family? What is she protecting? What is she hiding?* *The Voss question is no longer background noise. It is the loudest signal in the data.* --- 6:00 PM. Leah left the building and walked home through the cold evening. Her mind was racing — the document retrieval request, the executive briefing, the Voss Foundation payment. Each thread was pulling in the same direction, toward a center that she still couldn't see. At her apartment, she called Ethan. This time, he answered on the second ring. "I have an update," she said. "Go ahead." She told him about the document retrieval request — the justification, the estimated timeline, the temporary access to the 36th floor. She told him about the executive briefing preparation and the possibility of presenting on the 40th floor. Then she told him about the Voss Foundation payment. Ethan was quiet for a long time. Longer than his usual three-second pause. "Voss Medical Research Foundation," he repeated. "$45,000 from Costa Holdings. Dissolved in 2021. Assets transferred to the Thorne Foundation." "Yes." Another silence. Then: "The Foundation was incorporated in 2019. By Pemberton & Croft. The same firm that handles the shell company registrations." "Yes. And the property — 87 Rimrock Road, Southampton — was transferred to Martha as trustee. The same pattern as the other Voss-connected assets." "Catherine." He used her cover name. A deliberate choice. "The Voss Medical Research Foundation was created for one purpose: to launder the Voss family's remaining assets into the Thorne Foundation. James and Elena Voss died with a research grant and a property in Southampton. Martha created a foundation to absorb both, then dissolved the foundation and transferred everything to herself." "That's what it looks like." "It's more than that." His voice had changed — lower, tighter. The controlled banker's tone was cracking. "The pediatric clinical trial that the Foundation was supposedly funding — the one Costa Holdings paid $45,000 a year for — I've seen references to it before. In my parents' files. The Hunt family made a donation to the same foundation in 2020. My mother's handwriting. 'For the children,' she wrote." The connection. Ethan's adoptive parents had donated to the Voss Medical Research Foundation. The same foundation that Martha Thorne had created to absorb the Voss family's assets. The same foundation that was somehow connected to Leah's own identity. "Ethan." "I know." His voice was raw. "I know what you're going to ask. And I'm not ready. Not yet." "Okay." "But you're right. The Voss question is the center. Everything else — the shell companies, the PRI program, the FDA letter, the NexGen deal — it all radiates outward from whatever happened to the Voss family twenty-four years ago." "And whatever happened to me." "Yes." A pause. "Whatever happened to you." The line was quiet. Leah could hear traffic outside Ethan's window, or her own — she couldn't tell. "I'm getting access to the 36th floor," she said. "Maybe within a week. If the physical archive has pre-2015 documents, I might find something." "Be careful." "I'm always careful." "No." His voice softened. "You're not. You're reckless in the way that brave people are reckless — you think the mission matters more than your safety. It doesn't. Not to me." Leah didn't respond to that. She wasn't ready. "I'll send you the document retrieval request number," she said. "So you can track it independently." "Do that." "Goodnight, Ethan." "Goodnight." She hung up and sat in the dark apartment for a long time. The Moleskine was open on the floor beside her. She picked it up and wrote: *March 28. Day four.* *The Voss name is everywhere. In the financial records, in the foundation documents, in Ethan's voice when he says it. Something happened to the Voss family that Martha Thorne has spent twenty-four years burying. And I am connected to it.* *The retrieval request is in. The 36th floor is within reach. Geraldine Hoffman is the next door.* *But the Voss question is the key that opens every door.* *And Ethan is holding a piece of that key.* *He said he wasn't ready. I believe him. But time is not infinite, and Martha is not patient. If Ethan's connection to the Voss family is what I think it is, he may be the only person who can fill the gap between what I know and what I need to know.* *The alliance is real. But it is not complete.* *It will not be complete until Ethan tells me the truth.* Leah closed the Moleskine and turned off the lamp. The city hummed beyond the window. The investigation was deepening, the threads were converging, and the Voss question was rising from background noise to the dominant signal. Catherine Marsh was doing her job. Isabella Thorne was getting closer to the truth. And somewhere in the space between those two identities, Leah was beginning to feel the weight of what she might find. ---